LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO).
暂无分享,去创建一个
B. Alekseev | K. Chi | N. Tran | A. Protheroe | P. De Porre | L. Fein | K. Fazazi | N. Matsubara | S. Feyerabend | S. Mundle | Susan Li | G. Sulur | M. Ozguroglu | A. R. Antolín | S. Li | A. Rodríguez Antolín | P. Porre | Nobuaki Matsubara | Kim N. Chi | Luis Fein | Andrew Protheroe | Kim N. Chi | A. Protheroe